Results 181 to 190 of about 387,731 (304)

CT and MRI Manifestations of Pancreatic Hemangioma: A Literature Review and a New Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Pancreatic hemangioma is an extremely rare benign tumor occurring in the pancreas. Preoperative diagnosis is challenging due to its lack of specificity in clinical manifestations and imaging examinations. A pancreatic lesion was found during physical examination of a 54‐year‐old woman who had no symptoms of abdominal discomfort.
Jing Zhang, Jingjing Chen, Dongmei Zou, Xu Cao   +3 more
wiley   +1 more source

Mucinous adenocarcinoma transformed from tailgut cyst: a case report and review of the literature. [PDF]

Front Oncol
Guo Q, Parker JB, Henderson A, Khoor A, Mohseni MM.   +4 more
europepmc   +1 more source

Appendix Mucinous Adenocarcinoma [PDF]

, 2020
openaire   +1 more source

Nanogel‐Mediated Immunotherapy to Tackle Cancer and Inflammatory Diseases

ChemistryEurope, Volume 4, Issue 2, February 2026.
Nanogels formed through self‐assembly, microemulsion, or precipitation polymerization method enable precise delivery of immunotherapeutic factors and immune cell targeting, thus effectively modulating immune responses. This review highlights recent advances in stimuli‐responsive nanogel design, underlying mechanisms, and their potentials to tackle ...
Ziwen Zhang, Jinxia Wang, Guang‐Zhi Jin, István Bányai, Dzmitry Shcharbin, Ivan Stoikov, Mingwu Shen, Xiangyang Shi   +7 more
wiley   +1 more source

Primary Ovarian Poorly Differentiated Adenocarcinoma with Signet-Ring Cells: A Case Report and Literature Review. [PDF]

J Clin Med
Koo YJ, Jang MH, Lee DH.
europepmc   +1 more source

Cystic masses of the pancreas : how useful is cyst fluid analysis in the diagnosis? [PDF]

, 2011
Cesmeli, Ercan, Claerhout, Barbara, De Vos, Martine, Ferdinande, Liesbeth, Laurent, Stéphanie, Peeters, Marc   +5 more
core   +1 more source

Ovarian Mucinous Adenocarcinoma [PDF]

, 2020
openaire   +1 more source

Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden‐High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment

Cancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Pembrolizumab is approved for treating patients with advanced solid tumors exhibiting high tumor mutation burden (TMB), including pancreatic cancer. However, owing to the rarity of TMB‐high pancreatic cancer, its genetic and clinical characteristics, alongside the therapeutic effectiveness of pembrolizumab, remain unclear.
Yugo Kai, Kenji Ikezawa, Kazuhiro Kozumi, Makiko Urabe, Ryoji Takada, Takumi Kinomoto, Takanori Masumoto, Masaki Kawabata, Hiroki Kishimoto, Kana Hosokawa, Kaori Mukai, Tasuku Nakabori, Yuko Yamaguchi, Naotoshi Sugimoto, Kazuyoshi Ohkawa   +14 more
wiley   +1 more source

Giant retroperitoneal mucinous adenocarcinoma of the appendix: a case report. [PDF]

J Surg Case Rep
Solomon A, Oliver-Monasterio D, Diaz G, Jreije K.   +3 more
europepmc   +1 more source

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley   +1 more source